Home/Filings/3/0001213900-21-025864
3//SEC Filing

Orion Sponsor Holdings, LLC 3

Accession 0001213900-21-025864

CIK 0001847416other

Filed

May 11, 8:00 PM ET

Accepted

May 12, 8:08 PM ET

Size

14.1 KB

Accession

0001213900-21-025864

Insider Transaction Report

Form 3
Period: 2021-05-12
Holdings
  • Class B ordinary shares

    Class A ordinary shares (5,630,000 underlying)
Footnotes (3)
  • [F1]As described in the issuer's registration statement on Form S-1 (File No. 333-253548) under the heading "Description of Securities-Founder Shares", the Class B ordinary shares, par value $0.0001, will automatically convert into Class A ordinary shares, par value $0.0001, of the issuer at the time of the issuer's initial business combination transaction on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.
  • [F2]The Class B ordinary shares owned by the reporting person include up to 750,000 shares that are subject to forfeiture to the extent the underwriters of the initial public offering of the issuer's securities do not exercise in full their over-allotment option as described in the issuer's registration statement.
  • [F3]This Form 3 is being filed by Orion Sponsor Holdings, LLC, sponsor of the issuer (the "Sponsor"). The Sponsor is managed by a board of managers comprised of James Huang, John Phelan and Robert Platek, who control the Sponsor. Accordingly, Messrs. Huang, Phelan and Platek have voting and investment discretion with respect to the securities held by the Sponsor, and may be deemed to have beneficial ownership of the securities held directly by the Sponsor. Each of Messrs. Huang, Phelan and Platek disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Issuer

Orion Biotech Opportunities Corp.

CIK 0001847416

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001847414

Filing Metadata

Form type
3
Filed
May 11, 8:00 PM ET
Accepted
May 12, 8:08 PM ET
Size
14.1 KB